Dazhong Chen
Overview
Explore the profile of Dazhong Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
31
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tian Y, Gu M, Chen D, Dong Q, Wang Y, Sun W, et al.
J Clin Hypertens (Greenwich)
. 2024 Oct;
27(1):e14925.
PMID: 39468693
Previous studies have suggested a link between the gut microbiome and hypertension-related traits like blood pressure. However, these reports are often limited by weak causal evidence. This study investigates the...
2.
Wang Y, Li S, Shi H, Guan X, Wei Q, Chen D
Cardiovasc Diagn Ther
. 2024 Sep;
14(4):679-697.
PMID: 39263485
Background And Objective: Immune checkpoint inhibitors (ICIs) have become one of the cornerstones of current oncology treatment, and immune checkpoint inhibitor-related myocarditis (IRM) is the most fatal of all immune...
3.
Chen D, Pan X, Xie F, Lu Y, Zou H, Yin C, et al.
Int J Nanomedicine
. 2018 Dec;
13:6855-6870.
PMID: 30498347
Purpose: Liver cancer is the third leading cause of cancer-related deaths worldwide. Liver cancer stem cells (LCSCs) are a subpopulation of cancer cells that are responsible for the initiation, progression,...
4.
Gong Z, Chen D, Xie F, Liu J, Zhang H, Zou H, et al.
Nanomedicine (Lond)
. 2016 Sep;
11(19):2565-2579.
PMID: 27647449
Aim: To develop salinomycin-loaded nanoliposomes (SLN), doxorubicin-loaded nanoliposomes (DLN) and nanoliposomes codelivering salinomycin and doxorubicin (SDLN) to target both liver cancer cells and cancer stem cells. Materials & Methods: The...